Drugs / Micronised Purified Flavonoid Fraction
Micronised Purified Flavonoid Fraction
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02907320 Comparator | Dec 2016 → May 2018 | chronic venous insufficiency | Pierre Fabre Laboratories | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Micronised Purified Flavonoid Fraction | “The aims of this research is to study the effects on microcirculatory activity (activity on very small vessels) of CYCLO 3 ® FORT, MPFF (Micronised Purified Flavonoid Fraction)...” NCT02907320 ↗ |
| Known as | Micronized Purified Flavonoid Fraction | “MPFF = Micronized Purified Flavonoid Fraction” NCT02907320 ↗ |
| Known as | MPFF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02907320 ↗ |